US · Healthcare

Kaken Pharmaceutical Co. Ltd (KKPCF)

Drug Manufacturers - Specialty & Generic

Kaken Pharmaceutical Co. Ltd (KKPCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KKPCF

P/E ratio

18.00

Kaken Pharmaceutical Co. Ltd (KKPCF) — FAQ

What is KKPCF's P/E ratio?

The price-to-earnings (P/E) ratio for Kaken Pharmaceutical Co. Ltd (KKPCF) is 18.00 (data as of 2026-03-24).

Does Kaken Pharmaceutical Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Kaken Pharmaceutical Co. Ltd (KKPCF). Check the MyAverix Finance app for the latest dividend data.

What sector is Kaken Pharmaceutical Co. Ltd in?

Kaken Pharmaceutical Co. Ltd (KKPCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is KKPCF listed on?

KKPCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)